Manulife (Manufacturers Life Insurance)
WHWK

Manulife (Manufacturers Life Insurance)’s Whitehawk Therapeutics WHWK Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-30,330
Closed -$147K – 3033
2023
Q3 		$147K Sell
30,330
-2,437
-7% -$14.2K ﹤0.01% 2693
2023
Q2 		$224K Sell
32,767
-5,762
-15% -$44.8K ﹤0.01% 2546
2023
Q1 		$279K Hold
38,529
– – ﹤0.01% 2350
2022
Q4 		$486K Sell
38,529
-283
-0.7% -$3.69K ﹤0.01% 2015
2022
Q3 		$535K Buy
38,812
+40
+0.1% +$526 ﹤0.01% 1936
2022
Q2 		$499K Buy
38,772
+11,945
+45% +$177K ﹤0.01% 2063
2022
Q1 		$463K Buy
+26,827
New +$514K ﹤0.01% 2254

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s WHWK Position: Q4 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Whitehawk Therapeutics (WHWK) in Q4 2023, closing a stake of 30,330 shares — an estimated $147K sold.

Manulife (Manufacturers Life Insurance) first reported a position in WHWK in Q1 2022 and held it in 7 quarters. The position peaked at $535K in Q3 2022. 65 funds tracked by Wall St. Rank hold WHWK as of Q4 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining Whitehawk Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 30,330 Whitehawk Therapeutics shares in Q4 2023, an estimated $147K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Whitehawk Therapeutics in Q1 2022 and held it in 7 quarters.
  • Manulife (Manufacturers Life Insurance)'s Whitehawk Therapeutics position peaked at $535K in Q3 2022.
  • 65 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2023, filed 13 Feb 2024.